WOWen Ouyang

Wen Ouyang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wen Ouyang has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Conghua Xie

    Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China

    3 shared publications
  • Fajian He

    Department of Pulmonary Oncology Zhongnan Hospital of Wuhan University Wuhan 430071 China

    2 shared publications
  • Hang Xiao

    College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310058, China; Department of Food Science, University of Massachusetts, Amherst 01003, USA

    2 shared publications
  • Linzhi Han

    Department of Pulmonary Oncology Zhongnan Hospital of Wuhan University Wuhan 430071 China

    2 shared publications
  • Yan Gong

    Tumor Precision Diagnosis and Treatment Technology and Translational Medicine Hubei Engineering Research Center Zhongnan Hospital of Wuhan University Wuhan China

    2 shared publications
  • Yong Cao

    Guangdong Provincial Key Laboratory of Nutraceuticals and Functional Foods, College of Food Science, South China Agricultural University, Guangzhou 510642, China

    2 shared publications

Latest Publications

  • Open Access

    TMEM131‐Mediated Soluble TRAIL Triggered Type II Alveolar Epithelial Cell Senescence in Radiation‐Induced Lung Injury

    by Linzhi Han, Chunsheng Wang, Xiuli Guo, Yuan Luo, Jianguo Zhang, Fajian He, Zihang Zeng, Jiang Luo, Wen Ouyang, Yan Gong, et al.

    Radiation‐induced lung injury (RILI) limits radiotherapy dose for thoracic tumors. It is currently urgent to clarify RILI pathogenesis and find safe and effective therapeutical strategy. Transcriptomics of RILI mouse lungs indicate that cellular senescence is substantially involved in RILI pathogenesis, and anti‐senescence compounds alleviate RILI and pulmonary inflammatory. Single‐cell RNA sequencing and multi‐color immunofluorescence demonstrate that type II alveolar epithelial cells (AECIIs) are the main senescent cells, and quantitative proteomics illustrate that tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) is more secreted. Clinical samples also confirms that the plasma levels of TRAIL are significantly increased in RILI patients. Mechanistically, AECII‐specific TRAIL knockout ( Trail f/f ;Sftpc‐Cre ) mice presents reduced cellular senescence and RILI, accompanied by reduced mitophagy. Soluble TRAIL activates the mTOR pathway through death receptor 5 to hinder mitophagy, resulting in impaired mitochondrial accumulation and cellular senescence. Immunoprecipitation mass spectrometry identifies that endoplasmic reticulum (ER)‐localized transmembrane molecule TMEM131 interact with TRAIL and mediates its transportation from ER to Golgi through Sec23 homolog A of the coat protein complex II. Interruption of this transportation process led to ER‐associated degradation of TRAIL proteins through ubiquitylation. The results indicate the pro‐senescent role of TRAIL during RILI pathogenesis and reveals the TMEM131‐mediated intricate secretory process of TRAIL.


  • Open Access

    The interaction of flooding discharge and channel topography on morphodynamic processes in a partially confined braided river on the Qinghai-Tibet Plateau

    by Weiqi Ouyang, Zhiwei Li, Baoxin Jiang, Yucong He, Yunshuo Cheng, Zhixian Cao

    Global warming exacerbates the magnitude and peak of flood discharge in braided rivers on the Qinghai-Tibet Plateau (QTP). The interaction between inter-annually increasing peak discharge and local-topographical constrained braided riverbeds remains unclear. Thereby, hydrodynamic processes and sediment transport under various flood magnitudes were simulated in a partially confined braided reach which is a bending-shape channel forced by confining valley in the Source Region of the Yangtze River on the QTP. We elaborate the influence of flood magnitude on local morphological changes in the topographically confined braided channel. These findings may also inform management and ecological considerations in other high-elevation braided river systems. The main results are summarized as follows: (i) The outer bank experienced predominant erosion under the flood process, with submerged and highly migrated sandbars, while the inner bank exhibits the opposite characteristics. (ii) Inactive channels on the inner bank reactivated under higher peak discharges, increasing braiding density. (iii) Owing to the sinuous boundary, flow velocity at the outer part of the mainstream (near outer bank) is significantly higher than of the inner part, causing intense erosion and incision. This study is of great importance on uncovering the morphodynamic processes of partly confined braided rivers on the QTP.


  • Open Access

    Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion

    by Jianguo Zhang, Yangyi Li, Weijing Dai, Fang Tang, Lanqing Wang, Zhiying Wang, Siqi Li, Qian Ji, Junhong Zhang, Zhengkai Liao, et al.

    Background: Due to individual differences in tumors and immune systems, the response rate to immunotherapy is low in lung adenocarcinoma (LUAD) patients. Combinations with other therapeutic strategies improve the efficacy of immunotherapy in LUAD patients. Although radioimmunotherapy has been demonstrated to effectively suppress tumors, the underlying mechanisms still need to be investigated. Methods: Total RNA from LUAD cells was sequenced before and after radiotherapy to identify differentially expressed radiation-associated genes. The similarity network fusion (SNF) algorithm was applied for molecular classification based on radiation-related genes, immune-related genes, methylation data, and somatic mutation data. The changes in gene expression, prognosis, immune cell infiltration, radiosensitivity, chemosensitivity, and sensitivity to immunotherapy were assessed for each subtype. Results: We used the SNF algorithm and multi-omics data to divide TCGA-LUAD patients into three subtypes. Patients with the CS3 subtype had the best prognosis, while those with the CS1 and CS2 subtypes had poorer prognoses. Among the strains tested, CS2 exhibited the most elevated immune cell infiltration and expression of immune checkpoint genes, while CS1 exhibited the least. Patients in the CS2 subgroup were more likely to respond to PD-1 immunotherapy. The CS2 patients were most sensitive to docetaxel and cisplatin, while the CS1 patients were most sensitive to paclitaxel. Experimental validation of signature genes in the CS2 subtype showed that inhibiting the expression of RHCG and TRPA1 could enhance the sensitivity of lung cancer cells to radiation. Conclusions: In summary, this study identified a risk classifier based on multi-omics data that can guide treatment selection for LUAD patients.


  • Open Access

    Dietary Avicularin Alleviated Type 2 Diabetes in Mice

    by Xiaoai Zhu, Wen Ouyang, Jianyin Miao, Ping Xiong, Konglong Feng, Minxiong Li, Yong Cao, Hang Xiao

    Many dietary flavonoids exist as glycosides in fruits and vegetables, and they are considered as bioactive food components potentially responsible for various health benefits. Type 2 diabetes mellitus is a complex and polygenic disease with increasing global prevalence. In this study, the inhibitory effects of avicularin (quercetin‐3‐O‐α‐arabinofuranoside), a flavonoid glycoside commonly found in apple and mango, were determined in the mice with high fat diet/streptozotocin induced type 2 diabetes. Our results demonstrated that dietary avicularin treatment (100 mg/kg/d) reduced levels of fasting blood glucose, TG and LDL‐C, improved β‐cell function, and suppressed hepatic steatosis in diabetic mice. Gene expression analysis by RNA‐Seq revealed that arachidonic acid metabolism, drug metabolism‐cytochrome P450, drug metabolism‐other enzymes, MAPK signaling pathway, metabolic pathways, metabolism of xenobiotics by cytochrome P450, p53 signaling pathway and retinol metabolism were the major pathways altered in the liver of the diabetic mice in comparison with that of the negative control mice (healthy mice). Within the type 2 diabetes mellitus related pathways, ADIPO, P13K, SOCS, VDCC, SUR1, GK, PYK genes were upregulated in diabetic mice compared to the healthy mice, and avicularin treatment significantly downregulated these genes in the diabetic mice. Within the PPAR pathways, the mRNA levels of FABP1, SCD‐1, SCP‐X, ADIPO, PEPCK were increased in the diabetic mice, and avicularin treatment effectively decreased the levels of these gens in the diabetic mice. Avicularin treatment also upregulated the genes such as CYP7A1, CYP8B1, and CYP4A1 that was downregulated in the diabetic mice in comparison with the healthy mice. Taken together, our results demonstrated the protective effects of avicularin against diabetes and provided a global view of the effects of avicularin on the complexity transcriptome in diabetic mice. Support or Funding Information This study was supported by the University of International Cooperation in Science and Technology Innovation Platform Project of Guangdong (2013gjhz0003), the Education Department of Guang zhou Province (Grant No. 2013J4100075), the National Natural Science Foundation of China (Grant No. 31201321).


  • Novel ent-Kaurane Diterpenoid from Rubus corchorifolius L. f. Inhibits Human Colon Cancer Cell Growth via Inducing Cell Cycle Arrest and Apoptosis

    by Xuexiang Chen, Xian Wu, Wen Ouyang, Min Gu, Zili Gao, Mingyue Song, Yunjiao Chen, Yanyin Lin, Yong Cao, Hang Xiao

    The tender leaves of Rubus corchorifolius L. f. have been consumed as tea for drinking in China since ancient times. In this study, a novel ent-kaurane diterpenoid was isolated and identified from R. corchorifolius L. f. leaves as ent-kaur-2-one-16β,17-dihydroxy-acetone-ketal (DEK). DEK suppressed the growth of HCT116 human colon cancer cells with an IC50 value of 40 ± 0.21 μM, while it did not cause significant growth inhibition on CCD-18Co human colonic myofibroblasts at up to100 μM. Moreover, DEK induced extensive apoptosis and S phase cell cycle arrest in the colon cancer cells. Accordingly, DEK caused profound effects on multiple signaling proteins associated with cell proliferation, cell death, and inflammation. DEK significantly upregulated the expression levels of pro-apoptotic proteins such as cleaved caspase-3, cleaved caspase-9, cleaved PARP, p53, Bax, and tumor suppressor p21Cip1/Waf1, downregulated the levels of cell cycle regulating proteins such as cyclinD1, CDK2, and CDK4 and carcinogenic proteins such as EGFR and COX-2, and suppressed the activation of Akt. Overall, our results provide a basis for using DEK as a potential chemopreventive agent against colon carcinogenesis.


  • Open Access

    Results on efficacy and safety of cancer treatment with or without tumor necrosis factor-related apoptosis-inducing ligand-related agents: A meta-analysis

    by Shaoxing Sun, Zonghuan Li, Li Sun, Chunxu Yang, Zijie Mei, Wen Ouyang, Bo Yang, Conghua Xie

    This meta‑analysis aimed to evaluate the currently available evidence on the efficacy and safety of cancer treatment with or without tumor necrosis factor‑related apoptosis‑inducing ligand (TRAIL)‑related agents. We conducted a systematic search through Medline, Cochrane Library and EMBASE electronic databases and manually searched the Journal of Clinical Oncology to identify randomized controlled trials (RCTs) conducted between 1995 and 2013 comparing the efficacy and safety results of cancer treatment with and without TRAIL‑related agents. The methodological quality of the included RCTs was assessed by the Cochrane Risk of Bias assessment tool. The outcome measurements included objective response rate (ORR), clinical benefit rate (CBR)̸disease control rate (DCR) and adverse events (AEs). The relevant data were analyzed using Review Manager 5.2 software. Grading of Recommendations Assessment Development and Evaluation was used to assess the quality of evidence and grade of recommendation. Four RCTs, including a total of 596 patients, were ultimately selected and analyzed. There were no statistically significant differences among the 4 RCTs regarding ORR [relative risk (RR)=0.92, 95% confidence interval (CI): 0.73‑1.15, P=0.45], CBR̸DCR (RR=0.92, 95% CI: 0.81‑1.05, P=0.21), progression‑free survival [hazard ratio (HR)=0.89, 95% CI: 0.75‑1.05, P=0.16], overall survival (HR=0.90, 95% CI: 0.74‑1.09, P=0.27), number of patients with any AEs (RR=0.99, 95% CI: 0.96‑1.03, P=0.77), number of patients with any severe AEs (RR=0.95, 95% CI: 0.78‑1.55, P=0.58), number of patients with ≥grade 3 AEs (RR=1.13, 95% CI: 0.93‑1.38, P=0.22) and number of fatal AEs (RR=1.14, 95% CI: 0.71‑1.81, P=0.59). The quality of evidence was considered to be moderate and the recommendation grades were weak. In conclusion, the benefits of TRAIL‑related agents in the treatment of cancer patients remain uncertain and further clinical trials are required.